Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test

Diagnostic Cytopathology

Volumn 44, Issue 12, 2016, Pages 969-974

  Ozturk, Mustafa ^a   Umudum, Haldun ^b   Alanbay, Ibrahim ^c   Ulubay, Mustafa ^c   Fidan, Ulas ^c   Dede, Murat ^c   Yenen, Müfit Cemal ^c  

^a Military Hospital of Etimesgut   (Turkey)

^b UFUK UNIVERSITY   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

cervical intraepithelial neoplasia; human papillomavirus DNA tests; low grade squamous intraepithelial lesions; postmenopausal period

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; COLPOSCOPY; CYTOLOGY; DIAGNOSTIC EQUIPMENT; FEMALE; GYNECOLOGIST; GYNECOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN TISSUE; IMAGE GUIDED BIOPSY; MAJOR CLINICAL STUDY; NONHUMAN; OBSTETRICS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX DYSPLASIA; WART VIRUS; AGED; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PATHOLOGY; VIROLOGY;

AGED; COLPOSCOPY; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; POSTMENOPAUSE; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX;

EID: 84981730784     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23556     Document Type: Article

References (22)

1. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group (ALTS). Human papillomavirus testing for triage of women with cytologic evidence of low grade squamous intraepithelial lesions: Baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397–402.
2. Sengul D, Altinay S, Oksuz H, Demirturk H, Korkmazer E. Population-based cervical screening outcomes in turkey over a period of approximately nine and a half years with emphasis on results for women aged 30–34. Asian Pac J Cancer Prev 2014;15:2069–2074.
3. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346–355.
4. Khuakoonratt N, Tangjitgamol S, Manusirivithaya S, et al. Prevalence of high grade squamous intraepithelial lesion (HSIL) and invasive cervical cancer in patients with low grade squamous intraepithelial lesion (LSIL) at cervical Pap smear. Asian Pac J Cancer Prev 2008;9:253–258.
5. American Society for Colposcopy and Cervical Pathology (ASCCP). 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Lower Genital Tract Disease 2013;17:S11–S12.
6. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) Prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 2013;208:385–393.
7. Castle PE, Jeronimo J, Schiffman M, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 2006;66:1218–1224.
8. Sherman ME, Schiffman M, Cox JT; ALTS Group. Effects of age and human papilloma viral load on colposcopy triage: Data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94:102–107.
9. Datta SD, Koutsky LA, Ratelle S, et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003–2005. Ann Intern Med 2008;148:493.
10. Zhao C, Zhao S, Heider A, Austin RM. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities. Arch Pathol Lab Med 2010;134:1130–1135.
11. Cuzick J, Cox T, Zhang G, et al. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. Int J Cancer 2013;132:959–966.
12. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. J Am Med Assoc 2002;287:2114–2119.
13. Stafl A, Wilbanks GD. An international terminology of colposcopy: Report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy. Obstet Gynecol 1991;77:313–314.
14. Darragh TM, Colgan TJ, Cox JT, et al.; Members of LAST Project Work Groups. The lower anogenital squamous terminology standardization project for HPV-associated lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Lower Genit Tract Dis 2012;16:205–242.
15. Brooks SE. Cervical cancer screening and the older woman: Obstacles and opportunities. Cancer Pract 1996;4:125–129.
16. Dresang LT. Colposcopy: An evidence-based update. J Am Board Fam Med 2005;18:383–392.
17. Katki HA, Schiffman M, Castle PE, et al. Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results. J Lower Genit Tract Dis 2013;17:43–49.
18. Arbyn M, Roelens J, Simoens C, et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev 2013;3:CD008054. DOI: 10. 1002/14651858.
19. Katki HA, Schiffman M, Castle PE, et al. Benchmarking CIN3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Lower Genit Tract Dis 2013;17:28–35.
20. Cotton S, Sharp L, Little J, et al. (Trial Of Management of Borderline and Other Low-grade Abnormal Smears Group TOMBOLA) The role of human papillomavirus testing in the management of women with low-grade abnormalities: Multicentre randomised controlled trial. BJOG 2010;117:645–659.
21. Bandyopadhyay S, Austin RM, Dabbs D, Zhao C. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med 2008;132:1874–1881.
22. Ronco G, Cuzick J, Segnan N, et al.; NTCC Working Group, HPV triage for low grade (LSIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid-based cytology. Eur J Cancer 2007;43:476–480.